Buscar resultados de ensayos clínicos
Antiphospholipid Syndrome - 44 Studies Found
Estado | Estudiar |
Not yet recruiting |
Nombre del estudio: Preconceptional Thromboprophylaxis in Recurrent PREGNANCY LOSSES Caused by Antiphospholipid Syndrome Condición:
|
Completed |
Nombre del estudio: Assessment of the Prevalence of Major Psychiatric Disorders in a Cohort of Women With Clinical Criteria Corresponding to Pure, Abortive-form, Obstetrical, Antiphospholipid Syndrome Condición:
Fecha: 2016-07-12 |
Completed |
Nombre del estudio: CoaguChek XS in Antiphospholipid Antibody Syndrome (APL) Patients Condición: Antiphospholipid Antibody Syndrome Fecha: 2014-05-13 Intervenciones:
|
Completed |
Nombre del estudio: Longitudinal Study of the Clinical and Haematological Cause of Women With Antiphospholipid Antibodies. Condición: Antiphospholipid Syndrome Fecha: 2005-09-13 |
Recruiting |
Nombre del estudio: Use of Warfarin After the First Trimester in Pregnant Women With APS Condición:
Fecha: 2014-11-25 Intervenciones:
|
Recruiting |
Nombre del estudio: Timing of Initiation of LMWH Administration in Pregnant Women With APS Condición:
Fecha: 2014-12-22 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Eculizumab to Enable Renal Transplantation in Patients With History of Catastrophic Antiphospholipid Antibody Syndrome Condición:
Fecha: 2009-12-09 Intervenciones: Drug: Eculizumab Eculizumab will be administered by intravenous infusion. Eculizumab will be administere |
Terminated |
Nombre del estudio: Hydroxychloroquine for the First Thrombosis Prevention in Antiphospholipid Antibody Positive Patients Condición: Antiphospholipid Syndrome Fecha: 2013-02-03 Intervenciones: Drug: Hydroxychloroquine Other Name: plaquenil |
Completed |
Nombre del estudio: Phase IIa Trial of ALXN1007 for the Treatment of Non-criteria Manifestations of Antiphospholipid Syndrome Condición: Antiphospholipid (aPL)-Positive Fecha: 2014-04-29 Intervenciones: Biological: Study Drug- ALXN1007 10 mg/kg IV q 2 weeks x 12 doses |
Completed |
Nombre del estudio: Low-molecular-weight Heparin (LMWH) Versus Unfractionated Heparin (UFH) in Pregnant Women With Recurrent Abortion Secondary to Antiphospholipid Syndrome Condición: Recurrent Abortion Fecha: 2010-01-19 Intervenciones:
|